Lupus and Vascular Disease: Updates From ACR 2018

Recent studies explore the vascular underpinnings of neuropsychiatric damage as well as the risk of resistant hypertension in patients with SLE.

References1. Mikdashi JA. Determinants of Major Neurocognitive Disorder (Vascular Dementia) in SLE: The Importance of Treatment Adherence of SLE Disease Activity and Cardiovascular Risk Factors [abstract]. Arthritis Rheumatol. 2018;70(suppl 10). Abstract 754. Accessed October 21, 2018.2. Gandelman JS, Khan OA, Shuey M, et al. Increased Incidence and Prevalence of Resistant Hypertension in Patients with Systemic Lupus Erythematosus: A Retrospective Cohort Study [abstract]. Arthritis Rheumatol. 2018;70(suppl 10). Abstract 706. Accessed October 21, 2018.This information is brought to you by Rheumatology Network and is not sponsored by, nor a part of, the American College of Rheumatology.

Related Videos
Allysa Saggese, NP | Credit: Weill Cornell Medicine
Zobair Younossi, MD, MPH | Credit: American College of Gastroenterology
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
© 2024 MJH Life Sciences

All rights reserved.